Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211328107> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W3211328107 endingPage "1085" @default.
- W3211328107 startingPage "1078" @default.
- W3211328107 abstract "Side-effects are frequently encountered in classic chemotherapy. However, the recent development of targeted treatments has resulted in a diminution of these. The most common side-effects are dermatological.To investigate cutaneous changes occurring in patients using classic and targeted chemotherapeutic agents, and the prevalence of these changes in the two groups.One hundred twenty-eight volunteer oncological patients using chemotherapeutic agents were included in this prospective study. Two subgroups were established, patients using classic and those using targeted chemotherapeutic agents.Xerosis was the most common side-effect, being seen in 93 (72.7%) of the 128 patients. Other common side-effects included alopecia, pruritus, mucositis, skin pigmentation, and palmar-plantar erythema. The most common side-effects in the classic chemotherapeutic group were xerosis seen in 71 (75.5%) patients, pruritus in 50 (53.2%), alopecia in 49 (52.1%), and nail changes in 43 (45.7%). The most common side-effects in the targeted chemotherapeutic group were xerosis seen in 22 (64.7%) patients, nail changes in 17 (50%), alopecia in 15 (44.1%), and pruritus in 13 (38.2%).The most common cutaneous side-effects were less prevalent in the patient group using targeted chemotherapeutic agents than in the classic group. Various side-effects associated with chemotherapeutic use which had not been previously reported were also identified in this study. Classic chemotherapeutic agents caused more serious side-effects requiring discontinuation of treatment than targeted chemotherapeutic agents." @default.
- W3211328107 created "2021-11-08" @default.
- W3211328107 creator A5022714654 @default.
- W3211328107 creator A5057654996 @default.
- W3211328107 date "2021-01-01" @default.
- W3211328107 modified "2023-10-11" @default.
- W3211328107 title "Evaluation of cutaneous side-effects associated with chemotherapeutic use in oncological patients" @default.
- W3211328107 cites W1585859626 @default.
- W3211328107 cites W1645179964 @default.
- W3211328107 cites W1998085563 @default.
- W3211328107 cites W2007287727 @default.
- W3211328107 cites W2020767396 @default.
- W3211328107 cites W2038021086 @default.
- W3211328107 cites W2039811370 @default.
- W3211328107 cites W2040978052 @default.
- W3211328107 cites W2062626434 @default.
- W3211328107 cites W2063147800 @default.
- W3211328107 cites W2081735720 @default.
- W3211328107 cites W2091677122 @default.
- W3211328107 cites W2106787323 @default.
- W3211328107 cites W2128103791 @default.
- W3211328107 cites W2387705900 @default.
- W3211328107 cites W2616005302 @default.
- W3211328107 cites W2616081246 @default.
- W3211328107 cites W2766879274 @default.
- W3211328107 cites W2884143739 @default.
- W3211328107 cites W2922505940 @default.
- W3211328107 doi "https://doi.org/10.5114/ada.2020.99943" @default.
- W3211328107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35126018" @default.
- W3211328107 hasPublicationYear "2021" @default.
- W3211328107 type Work @default.
- W3211328107 sameAs 3211328107 @default.
- W3211328107 citedByCount "6" @default.
- W3211328107 countsByYear W32113281072022 @default.
- W3211328107 countsByYear W32113281072023 @default.
- W3211328107 crossrefType "journal-article" @default.
- W3211328107 hasAuthorship W3211328107A5022714654 @default.
- W3211328107 hasAuthorship W3211328107A5057654996 @default.
- W3211328107 hasBestOaLocation W32113281071 @default.
- W3211328107 hasConcept C126322002 @default.
- W3211328107 hasConcept C16005928 @default.
- W3211328107 hasConcept C199360897 @default.
- W3211328107 hasConcept C2776694085 @default.
- W3211328107 hasConcept C2778496288 @default.
- W3211328107 hasConcept C2778715236 @default.
- W3211328107 hasConcept C2779121184 @default.
- W3211328107 hasConcept C3020391286 @default.
- W3211328107 hasConcept C3454156 @default.
- W3211328107 hasConcept C41008148 @default.
- W3211328107 hasConcept C71924100 @default.
- W3211328107 hasConceptScore W3211328107C126322002 @default.
- W3211328107 hasConceptScore W3211328107C16005928 @default.
- W3211328107 hasConceptScore W3211328107C199360897 @default.
- W3211328107 hasConceptScore W3211328107C2776694085 @default.
- W3211328107 hasConceptScore W3211328107C2778496288 @default.
- W3211328107 hasConceptScore W3211328107C2778715236 @default.
- W3211328107 hasConceptScore W3211328107C2779121184 @default.
- W3211328107 hasConceptScore W3211328107C3020391286 @default.
- W3211328107 hasConceptScore W3211328107C3454156 @default.
- W3211328107 hasConceptScore W3211328107C41008148 @default.
- W3211328107 hasConceptScore W3211328107C71924100 @default.
- W3211328107 hasIssue "6" @default.
- W3211328107 hasLocation W32113281071 @default.
- W3211328107 hasLocation W32113281072 @default.
- W3211328107 hasLocation W32113281073 @default.
- W3211328107 hasOpenAccess W3211328107 @default.
- W3211328107 hasPrimaryLocation W32113281071 @default.
- W3211328107 hasRelatedWork W2000752360 @default.
- W3211328107 hasRelatedWork W2034654114 @default.
- W3211328107 hasRelatedWork W2066040494 @default.
- W3211328107 hasRelatedWork W2066401884 @default.
- W3211328107 hasRelatedWork W2257482983 @default.
- W3211328107 hasRelatedWork W2531566930 @default.
- W3211328107 hasRelatedWork W3099335464 @default.
- W3211328107 hasRelatedWork W3132519199 @default.
- W3211328107 hasRelatedWork W3211328107 @default.
- W3211328107 hasRelatedWork W4295693356 @default.
- W3211328107 hasVolume "38" @default.
- W3211328107 isParatext "false" @default.
- W3211328107 isRetracted "false" @default.
- W3211328107 magId "3211328107" @default.
- W3211328107 workType "article" @default.